Repurposing of berbamine hydrochloride to inhibit Ebola virus by targeting viral glycoprotein

Repurposing of berbamine hydrochloride to inhibit Ebola virus by targeting viral glycoprotein

Ebola virus (EBOV) infection leads to staggeringly high mortality rate. Effective and low-cost treatments are urgently needed to control frequent EBOV outbreaks in Africa. In this study, we report that a natural compound called berbamine hydrochloride strongly inhibits EBOV replication in vitro and...

Full description

Bibliographic Details
Main Authors:	Dongrong Yi, Quanjie Li, Han Wang, Kai Lv, Ling Ma, Yujia Wang, Jing Wang, Yongxin Zhang, Mingliang Liu, Xiaoyu Li, Jianxun Qi, Yi Shi, George F. Gao, Shan Cen
Format:	Article
Language:	English
Published:	Elsevier 2022-12-01
Series:	Acta Pharmaceutica Sinica B
Subjects:	Ebola virus Drug repositioning Entry inhibitor Primed glycoprotein Structure-based virtual screening Protein–protein interaction
Online Access:	http://www.sciencedirect.com/science/article/pii/S2211383522002453

Similar Items

Requirements within the Ebola Viral Glycoprotein for Tetherin Antagonism
by: Nathan H. Vande Burgt, et al.
Published: (2015-10-01)

A Hyperstabilizing Mutation in the Base of the Ebola Virus Glycoprotein Acts at Multiple Steps To Abrogate Viral Entry
by: J. Maximilian Fels, et al.
Published: (2019-08-01)

Designs and Characterization of Subunit Ebola GP Vaccine Candidates: Implications for Immunogenicity
by: Valentina Agnolon, et al.
Published: (2020-11-01)

Analysis of Resistance of Ebola Virus Glycoprotein-Driven Entry Against MDL28170, An Inhibitor of Cysteine Cathepsins
by: Markus Hoffmann, et al.
Published: (2019-10-01)

Real-Time Analysis of Individual Ebola Virus Glycoproteins Reveals Pre-Fusion, Entry-Relevant Conformational Dynamics
by: Natasha D. Durham, et al.
Published: (2020-01-01)

The Methanolic Extract of <i>Perilla frutescens</i> Robustly Restricts Ebola Virus Glycoprotein-Mediated Entry
by: Yu-Ting Kuo, et al.
Published: (2021-09-01)

In silico-based vaccine design against Ebola virus glycoprotein
by: Dash R, et al.
Published: (2017-03-01)

Ebola Virus Glycoprotein Induces an Innate Immune Response In vivo via TLR4
by: Chih-Yun Lai, et al.
Published: (2017-08-01)

The Roles of Ebola Virus Soluble Glycoprotein in Replication, Pathogenesis, and Countermeasure Development
by: Wenjun Zhu, et al.
Published: (2019-10-01)

Structural and Functional Aspects of Ebola Virus Proteins
by: Sahil Jain, et al.
Published: (2021-10-01)

TIM-1 Augments Cellular Entry of Ebola Virus Species and Mutants, Which Is Blocked by Recombinant TIM-1 Protein
by: Min Zhang, et al.
Published: (2022-06-01)

Involvement of Surfactant Protein D in Ebola Virus Infection Enhancement via Glycoprotein Interaction
by: Anne-Laure Favier, et al.
Published: (2018-12-01)

A Systematic Review of Computational Drug Discovery, Development, and Repurposing for Ebola Virus Disease Treatment
by: James Schuler, et al.
Published: (2017-10-01)

Analysis of Determinants in Filovirus Glycoproteins Required for Tetherin Antagonism
by: Kerstin Gnirß, et al.
Published: (2014-04-01)

Computer-designed orthogonal RNA aptamers programmed to recognize Ebola virus glycoproteins
by: Yue Teng, et al.
Published: (2019-09-01)

Identification of 53 compounds that block Ebola virus-like particle entry via a repurposing screen of approved drugs
by: Jennifer Kouznetsova, et al.
Published: (2014-01-01)

Identification of active pocket and protein druggability within envelope glycoprotein GP2 from Ebola virus
by: Beuy Joob, et al.
Published: (2014-12-01)

Dendritic Cells/Macrophages-Targeting Feature of Ebola Glycoprotein and its Potential as Immunological Facilitator for Antiviral Vaccine Approach
by: Titus Abiola Olukitibi, et al.
Published: (2019-09-01)

Ebola-Detect: A differential serodiagnostic assay for Ebola virus infections and surveillance in the presence of vaccine-induced antibodies
by: Supriya Ravichandran, et al.
Published: (2022-08-01)

Selection, characterization, and thermal stabilization of llama single domain antibodies towards Ebola virus glycoprotein
by: Jinny L. Liu, et al.
Published: (2017-12-01)

Molecular docking study of anti-viral FDA-approved drugs as novel entry and replication Ebola viral inhibitors
by: Saghi Sepehri, et al.
Published: (2019-04-01)

Combinatorial peptide-based epitope mapping from Ebola virus DNA vaccines and infections reveals residue-level determinants of antibody binding
by: Daniel R. Ripoll, et al.
Published: (2017-12-01)

Development of an imaging system for visualization of Ebola virus glycoprotein throughout the viral lifecycle
by: Wakako Furuyama, et al.
Published: (2022-11-01)

Structural Studies of Henipavirus Glycoproteins
by: Aaron J. May, et al.
Published: (2024-01-01)

Chaperones, Membrane Trafficking and Signal Transduction Proteins Regulate Zaire Ebola Virus trVLPs and Interact With trVLP Elements
by: Dong-Shan Yu, et al.
Published: (2018-11-01)

Identification of Residues in Lassa Virus Glycoprotein Subunit 2 That Are Critical for Protein Function
by: Katherine A. Willard, et al.
Published: (2018-12-01)

Corrigendum: Chaperones, Membrane Trafficking and Signal Transduction Proteins Regulate Zaire Ebola Virus trVLPs and Interact With trVLP Elements
by: Dong-Shan Yu, et al.
Published: (2020-01-01)

Structurally Different Yet Functionally Similar: Aptamers Specific for the Ebola Virus Soluble Glycoprotein and GP1,2 and Their Application in Electrochemical Sensing
by: Soma Banerjee, et al.
Published: (2023-02-01)

MARCH8 Inhibits Ebola Virus Glycoprotein, Human Immunodeficiency Virus Type 1 Envelope Glycoprotein, and Avian Influenza Virus H5N1 Hemagglutinin Maturation
by: Changqing Yu, et al.
Published: (2020-10-01)

The Ebola-Glycoprotein Modulates the Function of Natural Killer Cells
by: Avishay Edri, et al.
Published: (2018-07-01)

Induction of ebolavirus cross-species immunity using retrovirus-like particles bearing the Ebola virus glycoprotein lacking the mucin-like domain
by: Ou Wu, et al.
Published: (2012-01-01)

Ébola (Enfermedad por el Virus del Ébola
by: Cristina Fernández Barrantes
Published: (2014-11-01)

Drug Repositioning for P-Glycoprotein Mediated Co-Expression Networks in Colorectal Cancer
by: Hande Beklen, et al.
Published: (2020-08-01)

Investigating Ebola virus pathogenicity using molecular dynamics
by: Morena Pappalardo, et al.
Published: (2017-08-01)

Ebola Virus Infections in Nonhuman Primates Are Temporally Influenced by Glycoprotein Poly-U Editing Site Populations in the Exposure Material
by: John C. Trefry, et al.
Published: (2015-12-01)

Ebola and Marburg virus matrix layers are locally ordered assemblies of VP40 dimers
by: William Wan, et al.
Published: (2020-10-01)

Single virus tracking of Ebola virus entry through lipid rafts in living host cells
by: Cong Jin, et al.
Published: (2020-03-01)

The Roles of Envelope Glycoprotein M in the Life Cycle of Some Alphaherpesviruses
by: Chunmei Li, et al.
Published: (2021-02-01)

Computational Study on Potential Novel Anti-Ebola Virus Protein VP35 Natural Compounds
by: Louis K. S. Darko, et al.
Published: (2021-11-01)

Determinants of the Bovine Leukemia Virus Envelope Glycoproteins Involved in Infectivity, Replication and Pathogenesis
by: Alix de Brogniez, et al.
Published: (2016-03-01)